Filing Details
- Accession Number:
- 0001209191-16-105765
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-03 19:09:27
- Reporting Period:
- 2016-03-01
- Filing Date:
- 2016-03-03
- Accepted Time:
- 2016-03-03 19:09:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1182657 | Md H Frank Valone | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-01 | 6,528 | $3.93 | 115,133 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-03-01 | 2,508 | $2.90 | 117,641 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-03-01 | 1,714 | $3.50 | 119,355 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-03-01 | 7,260 | $16.47 | 112,095 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-03-01 | 3,490 | $17.61 | 108,605 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-03-01 | 6,528 | $0.00 | 6,528 | $3.93 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-03-01 | 2,508 | $0.00 | 2,508 | $2.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-03-01 | 1,714 | $0.00 | 1,714 | $3.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,472 | 2019-08-11 | No | 4 | M | Direct | |
| 5,000 | 2020-06-09 | No | 4 | M | Direct | |
| 30,028 | 2021-06-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,000 | Indirect | By Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices between $16.02 and $17.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices between $17.02 and $17.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
